mFlusiva
-
Technology
FDA Approves Moderna’s First mRNA Seasonal Flu Vaccine mFlusiva
The U.S. Food and Drug Administration has approved Moderna Inc.’s seasonal influenza vaccine mFlusiva for adults aged 50 and older,…
Read More »
The U.S. Food and Drug Administration has approved Moderna Inc.’s seasonal influenza vaccine mFlusiva for adults aged 50 and older,…
Read More »